$PLX
Protalix BioTherapeutics, Inc. Common Stock
XASE•Health Care•Biological Products, (No Diagnostic Substances)
$2.71
▼-0.73%-$0.020
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateProtalix BioTherapeutics, Inc. Common Stock
XASE•Health Care•Biological Products, (No Diagnostic Substances)
Why is PLX down today? It is at $2.71 (-0.73%), and our scanner flagged it 37 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment PLX spikes, and full due diligence on PLX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $PLX 37 times in the last 30 days. Create a free account to track $PLX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
PLX is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on PLX today, peaking at 3.0x its normal volume.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Bashan Dror Officer | Bought (open market) | +56K 0.07% of company | added 42% | 189K | $101K at $1.81 | Dec 19, 25 |
Bar-Shalev Amos Director | Sold (automatic/other) | -168 | n/a | n/a | $314 at $1.87 | Nov 18, 25 |
Bashan Dror Officer | Acquired (grant/award) | +195K 0.2% of company | added 9.1% | 2.34M | n/a | Sep 3, 25 |
Ben Zvi Shmuel Director | Acquired (grant/award) | +8K | n/a | 8K | n/a | Sep 3, 25 |
Bar-Shalev Amos Director | Acquired (grant/award) | +8K | n/a | 8K | n/a | Sep 3, 25 |
Naos Yaron Officer | Acquired (grant/award) | +25K 0.03% of company | added 12% | 226K | n/a | Sep 3, 25 |
Elze Christian Director | Acquired (grant/award) | +8K | n/a | 8K | n/a | Sep 3, 25 |
Melincoff Gwen A Director | Acquired (grant/award) | +8K | n/a | 8K | n/a | Sep 3, 25 |
Schwartz Aharon Director | Acquired (grant/award) | +8K | n/a | 8K | n/a | Sep 3, 25 |
Boudes Pol F Director | Acquired (grant/award) | +8K | n/a | 8K | n/a | Sep 3, 25 |
Forster Eliot Director | Acquired (grant/award) | +8K | n/a | 8K | n/a | Sep 3, 25 |
Schwartz Aharon Director | Bought (open market) | +129K 0.2% of company | added 74% | 303K | $206K at $1.60 | Jun 10, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in biological products, (no diagnostic substances), closest in size first.
PLX is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on PLX today, peaking at 3.0x its normal volume.
PLX last traded at $2.71, down 0.73% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Protalix BioTherapeutics, Inc. Common Stock (PLX) is next expected to report earnings on Thursday, November 12, 2026, about 36 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The PLX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged PLX 37 times in the last 30 days.
PLX (Protalix BioTherapeutics, Inc. Common Stock) trades on XASE, with a market cap of about $220M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge PLX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$PLX discussion
Sign in to ask a question or join the discussion.